SPY328.52-9.70 -2.87%
DIA266.61-8.05 -2.93%
IXIC11,075.20-356.16 -3.12%

Morgan Stanley Maintains Overweight on Avrobio, Lowers Price Target to $34

Morgan Stanley maintains Avrobio (NASDAQ:AVRO) with a Overweight and lowers the price target from $35 to $34.

· 10/13/2020 08:24
Morgan Stanley maintains Avrobio (NASDAQ:AVRO) with a Overweight and lowers the price target from $35 to $34.